Bayesian Health Receives First FDA Clearance for Continuous AI Sepsis Monitoring
Bayesian Health has obtained FDA 510(k) clearance for its continuous AI sepsis monitoring device, marking the first approval of its kind. The system runs within the company’s clinical intelligence platform, providing continuous patient monitoring and early detection of sepsis before clinical suspicion.